ARCHIVES

RFP: Intellectual Property.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Rauscher Faces Flood Subcommittee, Unfriendly Obey

March 5, 1976

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

September 3, 1993

Letter: The Lesson From Dana-Farber

July 28, 1995

M.D. Anderson Must Evaluate 8 Patients In Controversial Study

May 31, 1996

Adding Aresenic To Therapy Improves APL Survival

July 27, 2007

Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval

August 31, 2012